A plaintiff attorney takes on a product liability case. The facts are compelling. The injury is documented. The product has a known defect history. The case looks strong.
The demand goes out. It comes back countered at a number that does not reflect the case’s apparent value. The defense seems more prepared than the facts warrant.
Nine months later, in deposition, it becomes clear why. The defense located records from a prior treating physician that were requested but never received. Those records document a pre-existing complaint that directly overlaps with the plaintiff’s alleged injury.
The records were listed in the original request. They were never followed up on. They never made it into the review.
The case settles significantly below where it should have.
This is not a rare scenario. It is a predictable one — and it is what a pre-litigation documentation audit is designed to prevent.
What a Pre-Filing Documentation Audit Is — and Why It Is Different From Standard Record Review
A standard medical record review processes the records in the file. A pre-filing documentation audit examines what should be in the file, what is missing, and what the existing records reveal about the case’s evidentiary strength before the complaint is filed.
The distinction matters because case valuation at intake is based on what the attorney knows. What the attorney knows is limited by what is in the file. A valuation built on an incomplete file is an inaccurate valuation — and in product liability cases, inaccurate valuations create settlement exposures that are difficult to recover from once discovery is underway.
The pre-filing audit does four things a standard review does not.
It maps the complete provider network. Every provider referenced in any record in the file is identified. Records requests are tracked against that provider list. Gaps are documented with specificity — which providers, which timeframes, what follow-up action is required.
It stress-tests the liability theory against the existing records. Before the complaint defines the theory of liability, the documentation audit examines whether the existing records support it. If the case is a failure-to-warn claim, are there records documenting the prescribing decision and what the physician knew? If it is a design defect claim, are there records establishing the causal link between product use and injury without gaps? Finding these questions before filing is preferable to encountering them in discovery.
It identifies documents that do not yet exist but should be requested. Pharmacovigilance reports, post-market surveillance data, manufacturer field complaint records — these are not medical records, but they are documents that belong in a product liability file. The audit identifies them as outstanding items and documents the request strategy.
It produces a baseline for ongoing review. As new records arrive during discovery, the audit baseline allows the legal team to track completeness against a defined standard. Records that arrive and don’t match the expected scope are flagged immediately rather than absorbed into a growing file without comment.
The Five Documentation Gaps That Consistently Appear Before Filing
Across product liability matters, five specific gaps appear with enough regularity to be considered predictable.
The prescribing physician’s records are absent. In drug and device cases, the physician who prescribed or implanted the product is a primary witness. Their records document the clinical decision, the risk disclosure, and the patient’s consent or lack of it. These records are frequently not included in the initial request because the focus is on the treating physicians who managed the injury.
The product use history is incomplete. For device cases, records documenting when the device was implanted, what the initial clinical indication was, and what follow-up examinations occurred are often spread across multiple facilities. The gap between implantation records and injury documentation — which may span years — is frequently under-reviewed.
Pharmacy records are treated as secondary. Pharmacy dispensing records establish the actual start date and dosage history for drug cases. Treating physician records describe the prescription. The two do not always match. When they don’t, that discrepancy matters to the causation analysis. Pharmacy records belong in the primary request, not in a supplemental request filed months later.
Prior treating records predate the claim window. Records from providers seen in the years before the alleged product injury often contain the most important evidence on alternative causation. Requests that focus on the injury period and not the years preceding it create a documentary blind spot that defense teams exploit consistently.
Manufacturer communications are not requested. Product liability cases involving drugs or devices have a regulatory paper trail — FDA correspondence, adverse event reports filed by the manufacturer, post-market study results. These records establish what the manufacturer knew and when. They are not medical records, but they belong in the file from the earliest stages.
How Documentation Audit Findings Change Settlement Strategy
A pre-filing documentation audit that reveals a strong, complete evidentiary record produces a different settlement conversation than one conducted without that foundation.
When the defense knows that plaintiff counsel has a fully audited file — complete provider network, no outstanding records, pharmacy records reconciled against prescribing records, manufacturer documents requested and received — the pre-trial settlement calculus changes. The defense has less room to argue that discovery will weaken the plaintiff’s position.
When the audit reveals gaps that can still be filled before filing, those gaps are filled. The complaint is filed on a stronger evidentiary foundation. The demand reflects what the evidence actually supports rather than what the facts appear to support at intake.
This is not a procedural nicety. In high-value product liability cases, the difference between a demand supported by a complete documented record and one supported by an incomplete file can be measured in settlement outcomes.
Expert FAQ: Product Liability Pre-Filing Documentation Audit
What is a product liability documentation audit, and when should it be commissioned?
A documentation audit is a structured review of what records should exist in a product liability matter, what records have been obtained, what gaps remain, and whether the existing records support the liability theory. It should be commissioned at intake — before the complaint is filed and before the case is valued. Audits commissioned after filing are still valuable but are reactive. They answer questions the defense has already identified. Audits commissioned before filing allow the legal team to address documentation gaps on their own timeline.
How does a documentation audit differ from a standard medical record review in a product liability case?
A standard review processes the records in the file. A documentation audit examines the file against a standard of completeness. It asks what is missing, identifies every provider referenced but not yet requested, maps the gap between expected documentation and actual documentation, and produces a remediation plan for outstanding records. The audit output includes not just what the records show, but what the records don’t show and why that matters to the case.
What is the most common documentation mistake made before filing a product liability case?
Requesting records only from providers who treated the injury, and not from providers who treated the plaintiff in the years preceding the alleged injury. Defense teams in product liability cases build their alternative causation arguments from pre-existing records. Plaintiff teams that have not reviewed the same records cannot respond to those arguments with specificity. This is a retrievable situation — but it is significantly better addressed before filing than in response to a defense expert report.
Do documentation audit standards differ for pharmaceutical versus medical device product liability cases?
Yes, in specific ways. For pharmaceutical cases, the audit should include a pharmacy records component — dispensing history establishing actual drug use — alongside prescribing and treating physician records. For medical device cases, the audit should cover the device’s implantation records, any prior device revision or replacement, and the manufacturer’s complaint history for the specific device model. Both case types require requesting post-market surveillance and regulatory communications from the manufacturer, but the clinical record scope differs.
What happens to the documentation audit findings if the case settles before trial?
The audit findings do not become less relevant if the case settles. A documented, complete evidentiary record supports a higher settlement demand. The audit findings are the evidentiary foundation for the demand letter and any mediation submissions. If the case settles, the documentation work supported that outcome. If it proceeds to trial, the same work is the foundation for expert engagement and discovery strategy.
Can CUBEXLE conduct a documentation audit on files that have already been reviewed by an internal team?
Yes. A second-layer audit on internally reviewed files is a common engagement. Internal reviews often have gaps in provider network completeness and in the identification of non-medical documents such as manufacturer communications and pharmacovigilance reports. An independent audit against those files produces a documented baseline that identifies what the internal review captured and what it did not.
CUBEXLE: Product Liability Documentation Audit and Support
CUBEXLE provides pre-filing documentation audits, medical record review, and litigation support services for product liability matters involving pharmaceutical products, medical devices, and consumer products.
We have worked with plaintiff and defense counsel on product liability matters for over 25 years. Our documentation audit methodology is built on a defined standard of completeness — not on what happened to arrive in the file.
HIPAA-compliant, ISO 27001-certified, SOC-compliant. Business Associate Agreements are standard for all engagements involving protected health information.